| # | Title | Journal | Year | Citations |
|---|
| 1 | The Beneficial Effect ofl-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial | Journal of Clinical Endocrinology and Metabolism | 2007 | 369 |
| 2 | The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis | Journal of Clinical Endocrinology and Metabolism | 2008 | 279 |
| 3 | AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures | Medical Journal of Australia | 2010 | 250 |
| 4 | The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11beta-hydroxysteroid dehydrogenase activity | Clinical Endocrinology | 1998 | 115 |
| 5 | Contemporary view of the clinical relevance of magnesium homeostasis | Annals of Clinical Biochemistry | 2014 | 85 |
| 6 | KLB , encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism | EMBO Molecular Medicine | 2017 | 77 |
| 7 | Influence of diabetes on peripheral bone mineral density in men: a controlled study | Acta Diabetologica | 2005 | 69 |
| 8 | SERIAL SERUM THYROGLOBULIN MEASUREMENTS IN THE MANAGEMENT OF DIFFERENTIATED THYROID CARCINOMA | Clinical Endocrinology | 1987 | 67 |
| 9 | Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone Shuttle | Hormone Research in Paediatrics | 2001 | 61 |
| 10 | 11β-Hydroxysteroid dehydrogenases, cell proliferation and malignancy | Journal of Steroid Biochemistry and Molecular Biology | 2003 | 55 |
| 11 | Effect of cancer treatment on hypothalamic–pituitary function | Lancet Diabetes and Endocrinology,the | 2015 | 55 |
| 12 | How should hypomagnesaemia be investigated and treated? | Clinical Endocrinology | 2011 | 54 |
| 13 | Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors | Annals of Internal Medicine | 2022 | 53 |
| 14 | Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy | Journal of Clinical Endocrinology and Metabolism | 2010 | 41 |
| 15 | Treatment of Hypomagnesemia | American Journal of Kidney Diseases | 2014 | 40 |
| 16 | Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review | Clinical Endocrinology | 2005 | 37 |
| 17 | Prolonged confusional state as first manifestation of COVID‐19 | Annals of Clinical and Translational Neurology | 2020 | 37 |
| 18 | Modulation by oestrogen of thyroid hormone effects on thyrotrophin gene expression | Journal of Endocrinology | 1987 | 34 |
| 19 | A comparison of the effects of bromocriptine and somatostatin on growth hormone gene expression in the rat anterior pituitary gland in vitro | Molecular and Cellular Endocrinology | 1987 | 27 |
| 20 | Peripheral bone density in patients with rheumatoid arthritis and factors which influence it | European Journal of Internal Medicine | 2002 | 24 |
| 21 | Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study | Orphanet Journal of Rare Diseases | 2015 | 24 |
| 22 | AMIODARONE AND THYROID HORMONE EFFECTS ON ANTERIOR PITUITARY HORMONE GENE EXPRESSION | Clinical Endocrinology | 1987 | 21 |
| 23 | Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline | The Lancet Child and Adolescent Health | 2021 | 21 |
| 24 | Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes | Clinical Endocrinology | 2017 | 20 |
| 25 | Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal | Clinical Endocrinology | 2018 | 20 |
| 26 | Defining renal phenotype in Alström syndrome | Nephrology Dialysis Transplantation | 2020 | 20 |
| 27 | Induction of hepatic 11β-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease | Clinical Endocrinology | 2008 | 18 |
| 28 | Effect of vitamin D deficiency in developed countries | British Medical Bulletin | 2017 | 18 |
| 29 | Vitamin D Deficiency in Traumatic Brain Injury and Its Relationship with Severity of Injury and Quality of Life: A Prospective, Observational Study | Journal of Neurotrauma | 2017 | 18 |
| 30 | The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds | Thyroid | 2016 | 17 |
| 31 | Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) – results from the feasibility randomised controlled trial | Thyroid Research | 2016 | 17 |
| 32 | EVALUATION OF A SENSITIVE CHEMILUMINESCENT ASSAY FOR TSH IN THE FOLLOW‐UP OF TREATED THYROTOXICOSIS | Clinical Endocrinology | 1987 | 16 |
| 33 | Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken? | Clinical Endocrinology | 2012 | 16 |
| 34 | Extensive experience in the management of macroprolactinomas | Clinical Endocrinology | 2014 | 11 |
| 35 | Mortality of Patients with Cushing’s Disease | Experimental and Clinical Endocrinology and Diabetes | 2021 | 11 |
| 36 | Thyroid status affects the regulation of prolactin mRNA accumulation by tri-iodothyronine and thyrotrophin-releasing hormone in cultured rat anterior pituitary cells | Journal of Endocrinology | 1987 | 10 |
| 37 | Cushing's Disease and tuberculosis | Respiratory Medicine | 1998 | 10 |
| 38 | Elevation of Free Thyroxine Measurements in Patients without Thyrotoxicosis | QJM - Monthly Journal of the Association of Physicians | 0 | 9 |
| 39 | Mortality and hypopituitarism | Growth Hormone and IGF Research | 1999 | 9 |
| 40 | Aspiration cytology of the thyroid. | BMJ: British Medical Journal | 1987 | 8 |
| 41 | Diabetic Medications in Pregnancy | Current Diabetes Reviews | 2009 | 8 |
| 42 | Communication with young people in paediatric and adult endocrine consultations: an intervention development and feasibility study | BMC Endocrine Disorders | 2017 | 8 |
| 43 | Mild primary hyperparathyroidism—to treat or not to treat? | British Medical Bulletin | 2019 | 8 |
| 44 | Mechanisms of TSH release: studies with forskolin, phorbol ester and A23187 | Molecular and Cellular Endocrinology | 1987 | 6 |
| 45 | Review: New perspectives in the management of primary hyperparathyroidism | Therapeutic Advances in Endocrinology and Metabolism | 2010 | 6 |
| 46 | Elevation of free thyroxine measurements in patients without thyrotoxicosis | The Quarterly Journal of Medicine | 1987 | 6 |
| 47 | Having the vision to measure calcium | Journal of Neurology | 2010 | 5 |
| 48 | Rebound vertebral and non‐vertebral fractures during denosumab interruption in a postmenopausal woman | Clinical Endocrinology | 2019 | 5 |
| 49 | Bone densitometry in clinical practice: longitudinal measurements at three sites in postmenopausal women on five treatments | Climacteric | 2001 | 4 |
| 50 | Regulation of TSH gene transcription | European Journal of Clinical Investigation | 1986 | 3 |
